Patents/Assignees

Supernus Pharmaceuticals, Inc.

10 patents in portfolio

US12569471utility2026
Method of Treatment of CNS Disorders
0 cites
US12454535utility2025
Substituted Derivatives of Isoindoles
0 cites
US12215097utility2025
Derivatives of Substituted Morpholines and Uses Thereof
0 cites
US12121523utility2024
Method of Treatment of Attention Deficit/hyperactivity Disorder (ADHD)
0 cites
US11964951utility2024
Process of Making Derivatives of Substituted Morpholines
0 cites
US11919889utility2024
Derivatives of Substituted Morpholines and Uses Thereof
0 cites
US11911368utility2024
Method of Treatment of CNS Disorders
0 cites
US11896599utility2024
Modified Release Preparations Containing Oxcarbazepine and Derivatives Thereof
0 cites
US11638708utility2023
Method of Treatment of Aggression
0 cites
US11634415utility2023
Derivatives of Substituted Morpholines and Uses Thereof
0 cites